Skip to main content
logo
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
45.33
-0.28 (-0.61%)
Aug 31, 2026, 4:00 PM EDT - Market closed

Novo Nordisk Income Statement

Millions DKK. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
78,48896,82379,14474,97676,85778,08785,68371,31168,06065,34965,86358,73154,30053,36748,09245,56641,26542,03138,33335,622
Revenue Growth (YoY)
2.12%23.99%-7.63%5.14%12.93%19.49%30.09%21.42%25.34%22.45%36.95%28.89%31.59%26.97%25.46%27.91%24.89%24.34%19.28%15.18%
Cost of Revenue
17,10013,59814,17014,47112,84612,89012,06211,30810,2749,9169,5689,7137,8568,1828,2627,2006,0696,9176,2416,059
Gross Profit
61,38883,22564,97460,50564,01165,19773,62160,00357,78655,43356,29549,01846,44445,18539,83038,36635,19635,11432,09229,563
Selling, General & Admin
16,30613,21717,14315,76118,84916,11220,27216,59216,09114,41318,62214,07515,41413,48315,09112,60911,83111,15312,82210,143
Research & Development
11,45910,28412,67111,49011,69010,3085,8129,48810,4668,6069,0928,1287,1276,7287,3255,6335,1235,2065,0594,252
Other Operating Expenses
234106-81-23-14238101-405568-309-9815-33-433-60-149-392-120-81
Operating Expenses
27,99923,60729,73327,25130,56226,40626,32226,18126,15223,58727,40522,10522,55620,17821,98318,18216,80515,96717,76114,314
Operating Income
33,38959,61835,24133,25433,44938,79147,29933,82231,63431,84628,89026,91323,88825,00717,84720,18418,39119,14714,33115,249
Interest Expense
-1,500--4,966--4,958--400--1,562-1,998-1,630-2,168--913-378----289-
Interest & Investment Income
1,314-4,4063075,314-613-9602,1462,1013,318--239---231-
Earnings From Equity Investments
---17----17---81----189----24-
Currency Exchange Gain (Loss)
-2,5543,196---1,758-1,070---76462---209-757---777-632-
Other Non Operating Income (Expenses)
---2411,528---289562---197-366852901-2,152-1,596-451-103-137
EBT Excluding Unusual Items
33,20362,17237,61935,08933,80537,03346,13634,38431,03231,91829,70728,06324,25424,73717,66318,03216,79517,91913,51415,112
Merger & Restructuring Charges
--89-9,455---------------124-
Gain (Loss) on Sale of Investments
--71----17---37----587---296-
Asset Writedown
-6,328--3,594-117---10,562--5,700--2,124----760----573-
Pretax Income
26,87562,17234,18525,51733,80537,03335,55734,38425,33231,91827,62028,06324,25424,73716,31618,03216,79517,91913,11315,112
Income Tax Expense
5,88613,6157,2945,5117,3027,9997,3277,0835,2826,5115,6575,5854,8264,9232,7243,6273,4773,7092,2212,993
Net Income
20,98948,55726,89120,00626,50329,03428,23027,30120,05025,40721,96322,47819,42819,81413,59214,40513,31814,21010,89212,119
Net Income to Common
20,98948,55726,89120,00626,50329,03428,23027,30120,05025,40721,96322,47819,42819,81413,59214,40513,31814,21010,89212,119
Net Income Growth (YoY)
-20.80%67.24%-4.74%-26.72%32.19%14.28%28.53%21.46%3.20%28.23%61.59%56.04%45.88%39.44%24.79%18.86%9.86%12.57%16.89%17.68%
Shares Outstanding (Basic)
4,4284,4434,4444,4444,4474,4394,4464,4524,4584,4604,4654,4774,4904,4994,5084,5234,5384,5534,5684,584
Shares Outstanding (Diluted)
4,4364,4494,4494,4474,4474,4464,4564,4614,4654,4714,4774,4894,5034,5134,5234,5374,5524,5674,5814,595
Shares Change (YoY)
-0.25%0.05%-0.14%-0.31%-0.42%-0.54%-0.49%-0.64%-0.83%-0.95%-1.00%-1.06%-1.09%-1.17%-1.27%-1.25%-1.31%-1.40%-1.48%-1.62%
EPS (Basic)
4.7410.936.054.505.966.546.356.134.505.704.925.024.334.403.023.182.933.122.382.64
EPS (Diluted)
4.7310.916.044.505.966.536.346.124.495.684.915.004.324.393.013.172.933.112.382.63
EPS Growth (YoY)
-20.61%67.07%-4.66%-26.47%32.74%14.96%29.15%22.40%3.94%29.39%63.07%57.73%47.44%41.16%26.47%20.30%11.41%14.13%18.81%19.23%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
42,52412,773-10,81032,47927,11311,308-3,80031,73140,0335,84014435,13822,69925,1212,14021,00921,52622,066-5,06620,332
Free Cash Flow Per Share
9.592.87-2.437.306.102.54-0.857.118.961.310.037.835.045.570.474.634.734.83-1.114.42
Dividend Per Share
3.750-7.950-3.750-7.900-3.500-6.400-3.000-4.075-2.125-3.450-
Dividend Growth (YoY)
0%-0.63%-7.14%-23.44%-16.67%-57.05%-41.18%-18.12%-21.43%-17.95%-
Gross Margin
78.21%85.96%82.10%80.70%83.29%83.49%85.92%84.14%84.90%84.83%85.47%83.46%85.53%84.67%82.82%84.20%85.29%83.54%83.72%82.99%
Operating Margin
42.54%61.57%44.53%44.35%43.52%49.68%55.20%47.43%46.48%48.73%43.86%45.82%43.99%46.86%37.11%44.30%44.57%45.55%37.39%42.81%
Profit Margin
26.74%50.15%33.98%26.68%34.48%37.18%32.95%38.28%29.46%38.88%33.35%38.27%35.78%37.13%28.26%31.61%32.27%33.81%28.41%34.02%
Free Cash Flow Margin
54.18%13.19%-13.66%43.32%35.28%14.48%-4.44%44.50%58.82%8.94%0.22%59.83%41.80%47.07%4.45%46.11%52.16%52.50%-13.22%57.08%
EBITDA
36,99463,13136,65536,49137,19342,55047,87535,84233,67134,00330,34629,43826,06526,72619,17422,22520,02720,79714,60016,598
EBITDA Margin
47.13%65.20%46.31%48.67%48.39%54.49%55.87%50.26%49.47%52.03%46.08%50.12%48.00%50.08%39.87%48.77%48.53%49.48%38.09%46.59%
D&A For EBITDA
3,6053,5131,4143,2373,7443,7595762,0202,0372,1571,4562,5252,1771,7191,3272,0411,6361,6502691,349
EBIT
33,38959,61835,24133,25433,44938,79147,29933,82231,63431,84628,89026,91323,88825,00717,84720,18418,39119,14714,33115,249
EBIT Margin
42.54%61.57%44.53%44.35%43.52%49.68%55.20%47.43%46.48%48.73%43.86%45.82%43.99%46.86%37.11%44.30%44.57%45.55%37.39%42.81%
Effective Tax Rate
21.90%21.90%21.34%21.60%21.60%21.60%20.61%20.60%20.85%20.40%20.48%19.90%19.90%19.90%16.70%20.11%20.70%20.70%16.94%19.80%
SEC Filings: 10-K · 10-Q